Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer ...

Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...

Digital PCR (dPCR) is an excellent tool for rare target analysis applications because, unlike traditional PCR methods, dPCR divides samples into thousands of individual microreactions, then ...

Investing.com -- Biodesix (NYSE:BDSX) stock rose 10% Wednesday after the diagnostics solutions company announced an expanded partnership agreement with Bio-Rad Laboratories to develop high complexity ...

Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using ...

Learn how a nutraceutical brand is investing in responsible and transparent manufacturing.

Biodesix (NYSE:BDSX) saw its stock jump 10% on Wednesday after announcing an expanded partnership with Bio-Rad Laboratories ...

The emergence of advanced therapy medicinal products (ATMPs) including cell therapies, has led to many bioanalytical ...

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...

Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...

Damian, one of my eighth-graders, left me a note on our digital bulletin board: “Science is my favorite class every year!” His classmate Amelia replied with “Me 2!!!” Damian is sure he’s headed for a ...